Bentham Science Logo

Track Your Manuscript:


Current Drug Discovery Technologies

Volume 17, 5 Issues, 2020
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Thematic Issue Proposal

Guest Editors who wish to submit an issue proposal to Current Drug Discovery Technologies are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Current Drug Discovery Technologies who will then inform Guest Editors with a decision about the submitted proposal.

Note: * Required fields

*Title of the proposed Thematic Issue:
*Guest Editor Name:
*Guest Editor Affiliation:
*Guest Editor's List of Publications (Last - 5 Years):
*Issue Description:
Proposal Keywords:
*Thematic Issue Type:
*Total Articles:
Tentative date for submission of ALL manuscripts:



Contact Information:

*Title:
*First Name:
*Last Name:
User Category:
*Address:
*City/Town:
*Country:
State/Province:
ZIP/Postal code:
*E-mail:
Phone:
Fax:

Editor-in-Chief

Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
(USA)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.42

New eBook

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog